Sonoma Pharmaceuticals
SNOA
#11037
Rank
A$8.14 M
Marketcap
A$1.61
Share price
-6.84%
Change (1 day)
-70.94%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -A$2.09 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are A$21.92 Million. In 2025 the company made an earning of -A$4.09 Million, an increase over its 2024 earnings that were of -A$6.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$2.09 Million-48.87%
2025 -A$4.09 Million-38.02%
2024 -A$6.59 Million0.54%
2023 -A$6.56 Million-31.5%
2022 -A$9.57 Million16.86%
2021 -A$8.19 Million194.32%
2020 -A$2.79 Million-58.76%
2019 -A$6.75 Million-65.66%
2018 -A$19.64 Million4.84%
2017 -A$18.73 Million-2.17%
2016 -A$19.15 Million32.12%
2015 -A$14.49 Million-307.74%
2014 A$6.97 M-197.5%
2013 -A$7.16 Million
2010 -A$11.18 Million-14.02%
2009 -A$13 Million-57.28%
2008 -A$30.43 Million-8.03%
2007 -A$33.09 Million3.85%
2006 -A$31.86 Million39.31%
2005 -A$22.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 11,217.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.8 Million 1,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA